Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of MOF on Patients After Open Surgery for a RAAA
Conditions: Preventive Medicine; Multi Organ Failure Interventions: Drug: Interferon Beta-1A; Drug: Placebo Sponsor: Faron Pharmaceuticals Ltd Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials
MEasuring Satisfaction of Treatment With REbif After Initial Treatment of MS (MESTRE-MS)
Condition: Multiple Sclerosis Intervention: Drug: Rebif (IFNβ-1b) Sponsors: Merck KGaA; Merck B.V., Netherlands Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2016 Category: Research Source Type: clinical trials